Outcomes Core

$342,931P01FY2013HLNIH

University Of Washington, Seattle WA

Investigators

Linked publications & trials

Paper 32426414 Paper 31945113 Paper 31723070 Paper 31587567 Paper 31564645 Paper 31375810 Paper 31049579 Paper 30587544 Paper 30566022 Paper 30190531 Paper 29969440 Paper 29942806 Paper 29888752 Paper 28813672 Paper 28684531 Paper 28562232 Paper 28553667 Paper 28483831 Paper 28065644 Paper 27906170 Paper 27737958 Paper 27716639 Paper 27600722 Paper 27503462 Paper 27161364 Paper 26955856 Paper 26866596 Paper 26807015 Paper 26755607 Paper 26607951 Paper 26487784 Paper 26395136 Paper 26388461 Paper 26269526 Paper 26161513 Paper 26153229 Paper 26076956 Paper 25980938 Paper 25978043 Paper 25964336 Paper 25865043 Paper 25795463 Paper 25342771 Paper 25290689 Paper 25093889 Paper 25087896 Paper 25070341 Paper 24838687 Paper 24819474 Paper 24780238 Paper 24776797 Paper 24735830 Paper 24687990 Paper 24685664 Paper 24672751 Paper 24628277 Paper 24615475 Paper 24516260 Paper 24481842 Paper 24141057 Paper 24131213 Paper 24127199 Paper 24118766 Paper 24090675 Paper 23959984 Paper 23953118 Paper 23924634 Paper 23911435 Paper 23793239 Paper 23723253 Paper 23722092 Paper 23637832 Paper 23530224 Paper 23520463 Paper 23517131 Paper 23463965 Paper 23461462 Paper 23448137 Paper 23391309 Paper 23071682 Paper 22981225 Paper 22864415 Paper 22660313 Paper 22512900 Paper 22400029 Paper 22362654 Paper 22353785 Paper 21925507 Paper 21886766 Paper 21822893 Paper 21597009 Paper 21593865 Paper 21474095 Paper 21293854 Paper 21211785 Paper 21187004 Paper 21186056 Paper 21084757 Paper 20854826 Paper 20696917

Abstract

Core B: Outcomes Core (Core B: Minami) The Outcomes Core has 4 objectives 1) To provide surgical models of myocardial infarction to serve as a basis for studying the effects of stem-cell therapy in myocardial infarct repair. 2) To provide in-vivo physiology endpoint measurements using echocardiography, MRI, and microspheres to determine functional improvement post-engraftment 3) To provide basic tissue preparation and sectioning to allow each project to study endpoints at the fissue level. 4) To develop a canine model of myocardial infarction and grafting techniques to allow us to study the effects of embryonic-stem cell derived cardiomyocytes and mesenchymal stem cells in large animal models so that we can be one step closer to bringing this therapy to the clinical setting.

View original record on NIH RePORTER →